Journal: Ophthalmology and Therapy

Article Title: Cost-Effectiveness of Presbyopia Correction Among Seven Strategies of Bilateral Cataract Surgery Based on a Prospective Single-Blind Two-Center Trial in China

doi: 10.1007/s40123-022-00562-3

Figure Lengend Snippet: Effectiveness, total costs, average cost-effectiveness ratios, and one-way sensitivity analyses of the seven strategies

Article Snippet: All patients underwent bilateral phacoemulsification and IOL implantation by experienced surgeons (Dr. Qi in center 1, Dr. Zeng in center 2) and were divided into seven strategies depending on patients’ requirements and preferences: (1) monofocal strategy: bilateral monofocal IOLs [AcrySof IQ SN60WF (Alcon Laboratories, Inc., Fort Worth, TX, USA) or Rayner 920H (Rayner Intraocular Lenses Ltd., Hove, East Sussex, UK)] targeting emmetropia; (2) monovision strategy: monofocal IOLs [AcrySof IQ SN60WF or Rayner 920H] targeting emmetropia in the dominant eye and myopia of − 2.00 D in the nondominant eye; (3) diffractive bifocal strategy: bilateral diffractive bifocal IOLs [AcrySof IQ ReSTOR + 3.0 D SN6AD1 (Alcon Laboratories, Inc., Fort Worth, TX, USA)] targeting emmetropia; (4) blended strategy: blended implantation diffractive bifocal IOLs with near additional power of + 2.5 D [AcrySof IQ ReSTOR + 2.5 D SV25T0 (Alcon Laboratories, Inc., Fort Worth, TX, USA)] in the dominant eye and + 3.0 D [SN6AD1] in the nondominant eye all targeting emmetropia; (5) refractive bifocal strategy, bilateral refractive bifocal IOLs [SBL-3 (Lenstec.

Techniques:

Journal: Ophthalmology and Therapy

Article Title: Cost-Effectiveness of Presbyopia Correction Among Seven Strategies of Bilateral Cataract Surgery Based on a Prospective Single-Blind Two-Center Trial in China

doi: 10.1007/s40123-022-00562-3

Figure Lengend Snippet: Cost categories for bilateral cataract surgery in the seven strategies ($/patient)

Article Snippet: All patients underwent bilateral phacoemulsification and IOL implantation by experienced surgeons (Dr. Qi in center 1, Dr. Zeng in center 2) and were divided into seven strategies depending on patients’ requirements and preferences: (1) monofocal strategy: bilateral monofocal IOLs [AcrySof IQ SN60WF (Alcon Laboratories, Inc., Fort Worth, TX, USA) or Rayner 920H (Rayner Intraocular Lenses Ltd., Hove, East Sussex, UK)] targeting emmetropia; (2) monovision strategy: monofocal IOLs [AcrySof IQ SN60WF or Rayner 920H] targeting emmetropia in the dominant eye and myopia of − 2.00 D in the nondominant eye; (3) diffractive bifocal strategy: bilateral diffractive bifocal IOLs [AcrySof IQ ReSTOR + 3.0 D SN6AD1 (Alcon Laboratories, Inc., Fort Worth, TX, USA)] targeting emmetropia; (4) blended strategy: blended implantation diffractive bifocal IOLs with near additional power of + 2.5 D [AcrySof IQ ReSTOR + 2.5 D SV25T0 (Alcon Laboratories, Inc., Fort Worth, TX, USA)] in the dominant eye and + 3.0 D [SN6AD1] in the nondominant eye all targeting emmetropia; (5) refractive bifocal strategy, bilateral refractive bifocal IOLs [SBL-3 (Lenstec.

Techniques: